Introduction To date, COVID‐19 has claimed 4.9 million lives. Diabetes has been identified
as an independent risk factor of serious outcomes in people with COVID‐19 infection …

Background The prevalence of bacterial infection in patients with COVID-19 is low, however,
empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …

Abstract Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated
with hyperinflammation. Despite the disproportionate incidence of Covid-19 among …

Background and Aim Currently, the number of patients with coronavirus disease 2019
(COVID-19) infection is increasing rapidly worldwide. In this study, we aimed to assess …

The outbreak of COVID-19 reminds us that the emerging and reemerging respiratory virus
infections pose a continuing threat to human life. Cytokine storm syndromes of viral origin …

Objective The COVID-19 pandemic is a biosecurity threat, and many resource-rich countries
are stockpiling and/or making plans to secure supplies of vaccine, therapeutics, and …

Objectives: People who are exposed to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) could develop a potentially fatal disease with lung involvement and severe …

Currently severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission has
been on the rise worldwide. Predicting outcome in COVID‐19 remains challenging, and the …

Olfactory and gustatory dysfunctions (OGD) are a frequent symptom of coronavirus disease
2019 (COVID-19). It has been proposed that the neuroinvasive potential of the novel SARS …

SARS-CoV-2 infection is often associated with severe inflammation, oxidative stress,
hypoxia and impaired physical activity. These factors all together contribute to muscle …